Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation-Reference-Cited by-同舟云学术

Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation

Published:2022-08-18 Issue:9 Volume:42 Page:697-706
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Braghieri Lorenzo¹²^ORCID,Jennings Douglas L.²,Bohn Bruno³,Habal Marlena²,Pinsino Alberto²,Mondellini Giulio M.²,Ladanyi Annamaria²,Latif Farhana²,Clerkin Kevin²,Restaino Susan²,Kurlansky Paul⁴,Takeda Koji⁴,Naka Yoshifumi⁴,Demmer Ryan T.³⁵,Sayer Gabriel T.²,Uriel Nir²,Colombo Paolo C.²,Yuzefpolskaya Melana²

Affiliation:

1. Department of Internal Medicine Cleveland Clinic Cleveland Ohio USA

2. Division of Cardiology Department of Medicine, Columbia University New York New York USA

3. Division of Epidemiology and Community Health University of Minnesota Minneapolis Minnesota USA

4. Department of Surgery, Division of Cardiac Surgery Columbia University New York New York USA

5. Department of Epidemiology, Mailman School of Public Health Columbia University Irving Medical Center New York New York USA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2724

Reference28 articles.

1. Report from the 2018 consensus conference on immunomodulating agents in thoracic transplantation: Access, formulations, generics, therapeutic drug monitoring, and special populations

2. Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians

3. Mycophenolate Mofetil Dose Reduction for Gastrointestinal Intolerance is Associated With Increased Rates of Rejection in Heart Transplant Patients

4. Mycophenolate Mofetil Dose Reduction and the Risk of Acute Rejection after Renal Transplantation

5. Impact of dose reductions on efficacy outcome in heart transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil at 12 months post-transplantation

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation;Transplantation;2024-02-16

2. Pharmacomicrobiomics of Classical Immunosuppressant Drugs: A Systematic Review;Biomedicines;2023-09-18